DEA Registration for Telehealth Practitioners: Everything You Need to Know

A DEA (Drug Enforcement Administration) registration is required for any practitioner who prescribes Schedule II–V controlled substances — including testosterone (Schedule III), which is the most commonly prescribed hormone in a men’s health telehealth practice. Understanding the DEA registration process, the telemedicine-specific provisions, and the ongoing compliance requirements is essential before prescribing begins.

Obtaining a DEA registration is a straightforward application process through the DEA’s Diversion Control Division online portal. You will need your state medical, nursing, or PA license (which must be in good standing), your National Provider Identifier (NPI), a valid practice address (which can be your home address for a home-based telehealth practice, or a registered agent address), and a credit card for the registration fee ($731 for a 3-year registration as of 2026). Processing time is typically 2–6 weeks for online applications.

Multi-state practice creates an important DEA consideration. A single DEA registration covers the state listed as the registered address — but you are only authorized to prescribe controlled substances in states where you hold state licensure, regardless of your DEA registration state. If you practice in multiple states, you may need multiple DEA registrations — one per state where you prescribe controlled substances to patients — or you may use your primary DEA registration in conjunction with state-specific controlled substance registrations (some states require a separate state CDS registration in addition to the DEA number).

The Ryan Haight Act requires that prescribers conduct at least one in-person medical evaluation before prescribing Schedule III–V substances via telemedicine, with specific exceptions. As the DEA’s proposed special registration rule for telemedicine continues to develop, practitioners should maintain current awareness of DEA guidance and consult with a healthcare attorney if any ambiguity exists regarding their specific prescribing situation.

DEA compliance is covered in detail in Session A of our Practitioner Training. Book here. Call 844-734-2112.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top